MXRA5
Basic information
Region (hg38): X:3308565-3346652
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (327 variants)
- not_provided (52 variants)
- Short_stature (2 variants)
- Prostate_cancer (1 variants)
- Nephrotic_syndrome (1 variants)
- MXRA5-related_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MXRA5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015419.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 19 | ||||
| missense | 316 | 26 | 10 | 352 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 317 | 36 | 19 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MXRA5 | protein_coding | protein_coding | ENST00000217939 | 6 | 38077 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0430 | 0.957 | 125710 | 17 | 21 | 125748 | 0.000151 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.728 | 1213 | 1.14e+3 | 1.06 | 0.0000928 | 18435 |
| Missense in Polyphen | 359 | 375.13 | 0.957 | 5770 | ||
| Synonymous | -0.195 | 481 | 476 | 1.01 | 0.0000424 | 5876 |
| Loss of Function | 5.12 | 14 | 55.0 | 0.255 | 0.00000413 | 996 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000680 | 0.000592 |
| Ashkenazi Jewish | 0.00134 | 0.000993 |
| East Asian | 0.000146 | 0.000109 |
| Finnish | 0.000126 | 0.0000924 |
| European (Non-Finnish) | 0.0000993 | 0.0000703 |
| Middle Eastern | 0.000146 | 0.000109 |
| South Asian | 0.000216 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: In kidney, has anti-inflammatory and anti-fibrotic properties by limiting the induction of chemokines, fibronectin and collagen expression in response to TGB1 and pro-inflammatory stimuli. {ECO:0000269|PubMed:27599751}.;
- Disease
- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:22696596}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0949
Intolerance Scores
- loftool
- 0.310
- rvis_EVS
- 1.57
- rvis_percentile_EVS
- 95.68
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- N
- hipred_score
- 0.384
- ghis
- 0.428
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.135
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- response to transforming growth factor beta
- Cellular component
- collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- extracellular matrix structural constituent